Latest Market Entry News

Page 2 of 56
Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.
Ada Torres
Ada Torres
4 Sept 2026
Memphasys has secured product registration for its Felix™ System in Turkey, marking the start of commercial sales with an initial order of 100 cartridges and two consoles. The move taps into a large assisted-reproduction market with strong growth potential.
Ada Torres
Ada Torres
3 Sept 2026
Imricor Medical Systems has reached a crucial milestone as the FDA accepts and closes the manufacturing module of its Premarket Approval submission, advancing its MR-guided electrophysiology devices closer to US market entry.
Ada Torres
Ada Torres
3 Sept 2026
Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.
Ada Torres
Ada Torres
31 Aug 2026
Adherium's FY2026 results show strong revenue gains from US remote patient monitoring but increased losses due to higher operating costs and commercial expansion.
Ada Torres
Ada Torres
31 Aug 2026
ClearVue Technologies saw a 35% revenue decline to $161,000 and a $11 million net loss in FY2026, driven by a major operational overhaul and significant product certification efforts. Despite the financial setback, the company expanded into new markets and secured key commercial projects.
Sophie Babbage
Sophie Babbage
31 Aug 2026
AML3D Limited surged to a record $12.5 million revenue in FY26, delivering its first half-year EBITDA profit and locking in a $29 million order book driven by US Defence contracts and UK market entry.
Victor Sage
Victor Sage
31 Aug 2026
X2M Connect Limited lifted revenue by 38% to $8.94 million in FY26, halving its net loss while laying groundwork for a new data centre business.
Sophie Babbage
Sophie Babbage
31 Aug 2026
CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.
Ada Torres
Ada Torres
31 Aug 2026
Nexsen Limited (ASX:NXN) reported a 30% rise in net loss to $6.55 million for FY26, driven by ongoing investment in its Group B Streptococcus rapid diagnostic and Asia-Pacific growth initiatives following its October 2025 IPO.
Ada Torres
Ada Torres
31 Aug 2026
Articore Group Limited (ASX:ATG) has swung to a $10.3 million EBIT profit in FY26, marking its first full-year profit since listing outside the pandemic spike, driven by margin gains and strategic acquisitions including India-based Frankly Wearing.
Victor Sage
Victor Sage
28 Aug 2026
Memphasys has secured early Thai FDA approval for its Felix™ System, triggering a three-year exclusive distribution deal with IVF Envimed and prompting additional orders amid strong clinic interest.
Ada Torres
Ada Torres
28 Aug 2026

Browse the archive

Full archive